---

ALAMEDA, CA - March 03, 2010 - Berkeley HeartLab, a subsidiary of Celera Corporation (NASDAQ:CRA), announced that its CLIA-registered laboratory was accredited by the College of American Pathologists (CAP) on February 19, 2010 following an inspection on February 2, 2010. The U.S. Centers for Medicare and Medicaid Services (CMS) has granted the CAP Laboratory Accreditation Program deeming authority, and its accreditations can also be used to meet many state certification requirements.

The CAP Laboratory Accreditation Program, begun in the 1960s, is an internationally recognized program for certifying laboratory quality based upon inspections conducted by practicing laboratory professionals.  The program utilizes a detailed checklist of thorough requirements to examine a laboratory.  CAP inspectors review a laboratory’s records and quality control of procedures for the preceding two years; the qualifications of all staff; equipment and facilities; safety program and record; and overall management.  

The CAP Program assures that a laboratory meets the highest standards of excellence by producing high quality test results that positively impact patient care.  Berkeley HeartLab fulfilled the key federal and state certification requirements necessary for achieving CAP accreditation, emphasizing the quality of the laboratory and the test results.   

What is CAP accreditation?

The goal of the CAP Laboratory Accreditation Program is to improve patient safety by advancing the quality of pathology and laboratory services through education, standard setting, and ensuring laboratories meet or exceed regulatory requirements. Upon successful completion of the inspection process, the laboratory is awarded CAP accreditation and becomes part of an exclusive group of more than 6,000 laboratories worldwide that have met the highest standards of excellence.

About the College of American Pathologists

The College of American Pathologists (CAP) is a medical society that serves more than 17,000 physician members and the laboratory community throughout the world. It is the world’s largest association composed exclusively of pathologists and is widely considered the leader in laboratory quality assurance. The CAP is an advocate for high quality and cost effective medical care.

About Berkeley HeartLab and Celera

Berkeley HeartLab, a subsidiary of Celera, offers services to predict cardiovascular disease risk and improve patient management. Celera is a healthcare business focusing on the integration of genetic testing into routine clinical care through a combination of products and services incorporating proprietary discoveries. Celera also commercializes a wide range of molecular diagnostic products through Abbott and has licensed other relevant diagnostic technologies developed to provide personalized disease management in cancer. Information about Celera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.celera.com.